FR2308368B1 - - Google Patents

Info

Publication number
FR2308368B1
FR2308368B1 FR7512916A FR7512916A FR2308368B1 FR 2308368 B1 FR2308368 B1 FR 2308368B1 FR 7512916 A FR7512916 A FR 7512916A FR 7512916 A FR7512916 A FR 7512916A FR 2308368 B1 FR2308368 B1 FR 2308368B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7512916A
Other languages
French (fr)
Other versions
FR2308368A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antonio Gallardo SA
Original Assignee
Antonio Gallardo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antonio Gallardo SA filed Critical Antonio Gallardo SA
Priority to FR7512916A priority Critical patent/FR2308368A1/en
Publication of FR2308368A1 publication Critical patent/FR2308368A1/en
Application granted granted Critical
Publication of FR2308368B1 publication Critical patent/FR2308368B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7512916A 1975-04-21 1975-04-21 Lysine salt of cephalexin - effect when administered parenterally as well as orally Granted FR2308368A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7512916A FR2308368A1 (en) 1975-04-21 1975-04-21 Lysine salt of cephalexin - effect when administered parenterally as well as orally

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7512916A FR2308368A1 (en) 1975-04-21 1975-04-21 Lysine salt of cephalexin - effect when administered parenterally as well as orally

Publications (2)

Publication Number Publication Date
FR2308368A1 FR2308368A1 (en) 1976-11-19
FR2308368B1 true FR2308368B1 (en) 1979-03-09

Family

ID=9154463

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7512916A Granted FR2308368A1 (en) 1975-04-21 1975-04-21 Lysine salt of cephalexin - effect when administered parenterally as well as orally

Country Status (1)

Country Link
FR (1) FR2308368A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins
ES412429A1 (en) * 1973-03-08 1976-01-01 Gallardo Antonio Sa Soluble salt of a cephalosporin

Also Published As

Publication number Publication date
FR2308368A1 (en) 1976-11-19

Similar Documents

Publication Publication Date Title
JPS5255946U (en)
JPS5245938B2 (en)
CH599638A5 (en)
BG22435A1 (en)
BG22449A1 (en)
BG22513A1 (en)
BG22555A1 (en)
BG22705A1 (en)
BG22760A1 (en)
BG22886A1 (en)
CH1132075A4 (en)
CH147275A4 (en)
CH22175A4 (en)
CH459576A4 (en)
CH585088A5 (en)
CH585623A5 (en)
CH586541A5 (en)
CH587100A5 (en)
CH587958A5 (en)
CH588273A5 (en)
CH588391A5 (en)
CH588601A5 (en)
CH589437A5 (en)
CH590124A5 (en)
CH592495A5 (en)

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
ST Notification of lapse